Several markers of survival among endometrial cancer (EC) patients have beenproposed, namely, the oncoprotein stathmin, RAF kinase inhibitor (RKIP),Cyclin A, GATA-binding protein 3 (GATA3), and growth and differentiationfactor-15 (GDF-15). This evidence concerns the gene PEBP1 and endometrial cancer.